MCRIi001-A-1

Not yet reviewed by Australian Stem Cell Registry

MCRIi001-A-OI26, PB001-OI26

Details

Tissue & Disease as reported

Disease as reported (Genomic Modifications)
osteogenesis imperfecta (Gene Knock-in) osteogenesis imperfecta (Isogenic modification)

Genetic Information

Genotype Locus
COL1A1
Polymorphism
Heterozygous: unspecified_reference_COL1A1:c.3969_3970insT
Modifications
Gene Knock-in Isogenic modification

Associated Publications

Line Custodianship

Cell Line Maintainer

Bateman

Affiliated Institutions
  • Murdoch Children's Research Institute, Melbourne, Australia
View all cell lines from this group

Cell Line Producer

Murdoch Children's Research Institute

Affiliated Institutions
  • Murdoch Children's Research Institute, Melbourne, Australia

Derivation Details

Induced Pluripotent Cell Derivation Details

Source Cell Type: CL:0000765
Label: erythroblast
Definition: A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers.

Source Cell Origin: UBERON:0000178
Label: blood
Definition: A fluid that is composed of blood plasma and erythrocytes.

Derivation Year:

Ethics

Ethics Number: 35121 A

Institution Human Research Ethics Council: RCH HUMAN RESEARCH ETHICS COMMITTEE

Approval Date: To be verified

Modifications

Genomic Modifications

A group of usually autosomal dominant inherited disorders characterized by defective synthesis of collagen type I resulting in defective collagen formation. It is characterized by brittle and easily fractured bones.

Mutation Type: Gene Knock-in
Delivery Method: crispr

Heterozygous: unspecified_reference_COL1A1:c.3969_3970insT

Introduction of heterozygous COL1A1:c.3969_3970insT variant in exon 49 leading to a frameshift and insertion of a premature stop codon. Synonymous changes were also introduced.

Cytoband: 17q21.33
Mutation Type: Isogenic modification
Delivery Method: CRISPR/Cas9

Quality Assurance

Genomic Characterisation

Passage Number: 2

Karyotype: arr(1-22)x2,(XY)x1

Karyotype Method: Molecular karyotyping by SNP array

Summary: Molecular karyotyping by SNP array (Illumina Infinium CoreExome-24 v1.1; resolution 0.5 Mb). SNPduo comparison to parental cell (>99.9% identity).

Microbiology and Virology Screening

Disease Result
Mycoplasma Negative

Characterisation of Undifferentiated Cells

Marker Method
NANOG Immunostaining
POU5F1 (OCT-4) Immunostaining
CD9 Flow cytometry
SSEA-3 Flow cytometry
TRA-1-81 Flow cytometry

Scorecard Results

Undifferentiated Cells

No available data for this cell line.

Pluripotency

No available data for this cell line.

Pluripotency Characterisation

Endoderm

In vitro directed differentiation

Assessed by: Flow cytometry

Markers: CXCR4;EPCAM

Mesoderm

In vitro directed differentiation

Assessed by: Flow cytometry

Markers: CD45

Ectoderm

In vitro directed differentiation

Assessed by: Immunostaining

Markers: NES;PAX6

Growth Characteristics

Culture Medium and Growth Conditions

CO2 concentration: 5%

O2 concentration: 95%

Medium Items:

  • Base Medium: KnockOut DMEM/F12 - Thermo Fisher Scientific Inc.
  • Serum: KnockOut Serum Replacement - Thermo Fisher Scientific Inc.
  • Supplement: GlutaMax - Thermo Fisher Scientific Inc.
  • Supplement: Non-Essential Amino Acid Solution - Thermo Fisher Scientific Inc.
  • Supplement: 2-mercaptoethanol - Thermo Fisher Scientific Inc.
  • Supplement: Fibroblast growth factor 2, Peprotech - Thermo Fisher Scientific Inc.

Passage Method: Enzyme-free cell dissociation

External References